Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis

Glasson, S.S. et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644–648 (2005).

Stanton, H. et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434, 648–652 (2005).

Gao, G. et al. ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol–anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1. J. Biol. Chem. 279, 10042–10051 (2004).

Brooks, P.M. The burden of musculoskeletal disease–a global perspective. Clin. Rheumatol. 25, 778–781 (2006).

Poole, A.R. et al. Proteolysis of the collagen fibril in osteoarthritis. Biochem. Soc. Symp. 70, 115–123 (2003).

Pattoli, M.A., MacMaster, J.F., Gregor, K.R. & Burke, J.R. Collagen and aggrecan degradation is blocked in interleukin-1–treated cartilage explants by an inhibitor of IκB kinase through suppression of metalloproteinase expression. J. Pharmacol. Exp. Ther. 315, 382–388 (2005).

Tortorella, M.D. et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 284, 1664–1666 (1999).

Abbaszade, I. et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J. Biol. Chem. 274, 23443–23450 (1999).

Bondeson, J., Wainwright, S., Hughes, C. & Caterson, B. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review. Clin. Exp. Rheumatol. 26, 139–145 (2008).

Song, R.H. et al. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum. 56, 575–585 (2007).

Tortorella, M.D., Liu, R.Q., Burn, T., Newton, R.C. & Arner, E. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol. 21, 499–511 (2002).

Tortorella, M.D. et al. ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms. Arch. Biochem. Biophys. 444, 34–44 (2005).

Wang, P. et al. Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network. J. Biol. Chem. 279, 15434–15440 (2004).

Longpré, J.M. et al. Characterization of proADAMTS5 processing by proprotein convertases. Int. J. Biochem. Cell Biol. 41, 1116–1126 (2009).

Tkachenko, E., Rhodes, J.M. & Simons, M. Syndecans: new kids on the signaling block. Circ. Res. 96, 488–500 (2005).

Molténi, A., Modrowski, D., Hott, M. & Marie, P.J. Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro. Bone 24, 337–347 (1999).

Cornelison, D.D., Filla, M.S., Stanley, H.M., Rapraeger, A.C. & Olwin, B.B. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev. Biol. 239, 79–94 (2001).

Echtermeyer, F. et al. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107, R9–R14 (2001).

Lim, S.T., Longley, R.L., Couchman, J.R. & Woods, A. Direct binding of syndecan-4 cytoplasmic domain to the catalytic domain of protein kinase C α (PKC α) increases focal adhesion localization of PKC α. J. Biol. Chem. 278, 13795–13802 (2003).

Wilcox-Adelman, S.A., Denhez, F. & Goetinck, P.F. Syndecan-4 modulates focal adhesion kinase phosphorylation. J. Biol. Chem. 277, 32970–32977 (2002).

Saoncella, S. et al. Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc. Natl. Acad. Sci. USA 96, 2805–2810 (1999).

Barre, P.E., Redini, F., Boumediene, K., Vielpeau, C. & Pujol, J.P. Semiquantitative reverse transcription-polymerase chain reaction analysis of syndecan-1 and -4 messages in cartilage and cultured chondrocytes from osteoarthritic joints. Osteoarthritis Cartilage 8, 34–43 (2000).

Clements, K.M. et al. Gene deletion of either interleukin-1β, interleukin-1β-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy. Arthritis Rheum. 48, 3452–3463 (2003).

Glasson, S.S. et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4–knockout mice. Arthritis Rheum. 50, 2547–2558 (2004).

Kamekura, S. et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 13, 632–641 (2005).

Blom, A.B. et al. Crucial role of macrophages in matrix metalloproteinase–mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum. 56, 147–157 (2007).

Mankin, H.J., Dorfman, H., Lippiello, L. & Zarins, A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J. Bone Joint Surg. Am. 53, 523–537 (1971).

Ostergaard, K., Andersen, C.B., Petersen, J., Bendtzen, K. & Salter, D.M. Validity of histopathological grading of articular cartilage from osteoarthritic knee joints. Ann. Rheum. Dis. 58, 208–213 (1999).

Pap, G. et al. Development of osteoarthritis in the knee joints of Wistar rats after strenuous running exercise in a running wheel by intracranial self-stimulation. Pathol. Res. Pract. 194, 41–47 (1998).